IL6-R blocking with tocilizumab in critically ill patients with hemophagocytic syndrome - Etienne Dufranc; Arnaud Del Bello; Julie Belliere; Nassim Kamar; Stanislas Faguer; on behalf of the TAIDI (Toulouse Acquired Immune Deficiency and Infection) study group (Critical Care, 2020)